Lessons from a glaucoma management clinic
At the completion of this CPD activity, optometrists will have developed their knowledge of glaucoma management. Including: Understand the structural ...
At the completion of this CPD activity, optometrists will have developed their knowledge of glaucoma management. Including: Understand the structural ...
Half a decade of data on the second generation iStent inject has shown a significant reduction in intraocular pressure (IOP) ...
Australian ophthalmologists have published the first independent head-to-head comparison of two leading minimally invasive glaucoma surgery (MIGS) devices, finding no ...
A pioneering solution for assessing glaucoma risk in clinical settings is closer to commercialisation with the support of a $304,000 ...
Ivantis has revealed new data from its five-year HORIZON pivotal trial showing its Hydrus Microstent device lowers the rate of ...
Glaucoma Australia (GA) has launched a new initiative encouraging Australians to share a photo of “an amazing sight” every day ...
Multinational ophthalmic company Alcon has agreed to acquire privately-owned Californian firm Ivantis – and its Hydrus Microstent minimally invasive glaucoma ...
A UNSW researcher from the university’s Graduate School of Biomedical Engineering has been awarded Glaucoma Australia (GA)’s ‘Quinlivan’ Research Grant ...
Designs For Vision is now supplying the iCare HOME2 tonometer, which it says revolutionises glaucoma care by enabling patients to ...
Eyetelligence is a new Australian-developed AI system helping clinicians screen for three types of eye disease. PROFESSOR MING HE – ...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited